Rebecca Robbins

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.

Donald Trump sued the Pulitzer Prize Board over its 2022 statement reaffirming its decision to award a prize for coverage of the 2016 Trump campaign’s ties to Russia.

Jun 21, 2024 ... Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government. New York Times pharmaceutical ...

The shot is no longer being manufactured or supplied, and it is no longer authorized for use in Europe.

Kevin Plank, the sports apparel company’s controlling shareholder, will seek to reinvigorate the struggling brand.

The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.

The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.

Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.